Dow Down0.62% Nasdaq Up0.35%

Illumina Inc. (ILMN)

-NasdaqGS
138.70 Down 0.79(0.57%) 4:00PM EST
|After Hours : 138.70 0.00 (0.00%) 4:25PM EST
ProfileGet Profile for:
Illumina Inc.
5200 Illumina Way
San Diego, CA 92122
United States - Map
Phone: 858-202-4500
Fax: 858-202-4766
Website: http://www.illumina.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company’s products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis. It also offers various library preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping, noninvasive prenatal test, and whole-genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has a collaboration agreement with Merck Serono to develop a sequencing-based oncology diagnostic; Burning Rock to develop molecular diagnostics for oncology; and Memorial Sloan Kettering Cancer Center to develop of strategies to diagnose and monitor cancer, and establish ctDNA as an important marker in the study and eventual treatment of cancer. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Illumina Inc.

Corporate Governance 
Illumina Inc.’s ISS Governance QuickScore as of Feb 1, 2016 is 10. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 9; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Jay T. Flatley , 63
Chairman and Chief Exec. Officer
2.12M98.48M
Mr. Francis A. deSouza , 45
Pres and Director
1.57M0.00
Dr. David R. Walt Ph.D., 63
Founder, Director and Member of Nominating & Corp. Governance Committee
57.00KN/A
Mr. Marc A. Stapley , 46
Chief Financial Officer, Chief Admin. Officer and Exec. VP
836.00K3.78M
Mr. Christian O. Henry , 47
Chief Commercial Officer and Exec. VP
896.00K15.34M
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders